nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinorelbine—ovarian cancer	0.842	1	CrCrCtD
Rescinnamine—ACE—vein—ovarian cancer	0.0144	0.293	CbGeAlD
Rescinnamine—SLC18A2—uterine cervix—ovarian cancer	0.00323	0.0657	CbGeAlD
Rescinnamine—SLC18A2—endometrium—ovarian cancer	0.00292	0.0595	CbGeAlD
Rescinnamine—ACE—embryo—ovarian cancer	0.00273	0.0555	CbGeAlD
Rescinnamine—SLC18A2—uterus—ovarian cancer	0.00269	0.0548	CbGeAlD
Rescinnamine—SLC18A2—female reproductive system—ovarian cancer	0.00242	0.0493	CbGeAlD
Rescinnamine—ACE—epithelium—ovarian cancer	0.00223	0.0453	CbGeAlD
Rescinnamine—SLC18A2—vagina—ovarian cancer	0.00219	0.0445	CbGeAlD
Rescinnamine—ACE—decidua—ovarian cancer	0.0021	0.0428	CbGeAlD
Rescinnamine—ACE—endometrium—ovarian cancer	0.002	0.0406	CbGeAlD
Rescinnamine—SLC18A2—testis—ovarian cancer	0.00196	0.0398	CbGeAlD
Rescinnamine—ACE—gonad—ovarian cancer	0.00185	0.0377	CbGeAlD
Rescinnamine—ACE—female reproductive system—ovarian cancer	0.00165	0.0336	CbGeAlD
Rescinnamine—ACE—bone marrow—ovarian cancer	0.00156	0.0317	CbGeAlD
Rescinnamine—ACE—female gonad—ovarian cancer	0.00151	0.0306	CbGeAlD
Rescinnamine—SLC18A2—lymph node—ovarian cancer	0.00142	0.0288	CbGeAlD
Rescinnamine—ACE—testis—ovarian cancer	0.00133	0.0271	CbGeAlD
Rescinnamine—Voacamine—ABCB1—ovarian cancer	0.00124	0.647	CrCbGaD
Rescinnamine—Dermatitis bullous—Topotecan—ovarian cancer	0.000974	0.00914	CcSEcCtD
Rescinnamine—ACE—lymph node—ovarian cancer	0.000968	0.0197	CbGeAlD
Rescinnamine—Dizziness—Altretamine—ovarian cancer	0.000957	0.00898	CcSEcCtD
Rescinnamine—Redness—Docetaxel—ovarian cancer	0.000927	0.0087	CcSEcCtD
Rescinnamine—Tingling sensation—Paclitaxel—ovarian cancer	0.000918	0.00862	CcSEcCtD
Rescinnamine—Eye irritation—Paclitaxel—ovarian cancer	0.000864	0.00811	CcSEcCtD
Rescinnamine—Nausea—Altretamine—ovarian cancer	0.000859	0.00806	CcSEcCtD
Rescinnamine—Pain—Carboplatin—ovarian cancer	0.000855	0.00802	CcSEcCtD
Rescinnamine—Accidental injury—Paclitaxel—ovarian cancer	0.000834	0.00783	CcSEcCtD
Rescinnamine—Dermatitis bullous—Vinorelbine—ovarian cancer	0.000833	0.00782	CcSEcCtD
Rescinnamine—Skin discolouration—Paclitaxel—ovarian cancer	0.000817	0.00767	CcSEcCtD
Rescinnamine—Lacrimation increased—Paclitaxel—ovarian cancer	0.000801	0.00752	CcSEcCtD
Rescinnamine—Eye irritation—Docetaxel—ovarian cancer	0.000733	0.00688	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Epirubicin—ovarian cancer	0.000709	0.00666	CcSEcCtD
Rescinnamine—Lacrimation increased—Docetaxel—ovarian cancer	0.000679	0.00637	CcSEcCtD
Rescinnamine—Reserpine—ABCB1—ovarian cancer	0.000675	0.352	CrCbGaD
Rescinnamine—Psoriasis—Epirubicin—ovarian cancer	0.000671	0.0063	CcSEcCtD
Rescinnamine—Angina pectoris—Vinorelbine—ovarian cancer	0.000671	0.00629	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Doxorubicin—ovarian cancer	0.000656	0.00616	CcSEcCtD
Rescinnamine—Hypertonia—Paclitaxel—ovarian cancer	0.000647	0.00607	CcSEcCtD
Rescinnamine—Rhinitis—Topotecan—ovarian cancer	0.000646	0.00606	CcSEcCtD
Rescinnamine—Hypoaesthesia—Topotecan—ovarian cancer	0.000641	0.00601	CcSEcCtD
Rescinnamine—Pharyngitis—Topotecan—ovarian cancer	0.000639	0.006	CcSEcCtD
Rescinnamine—Redness—Epirubicin—ovarian cancer	0.000625	0.00587	CcSEcCtD
Rescinnamine—Psoriasis—Doxorubicin—ovarian cancer	0.000621	0.00583	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Epirubicin—ovarian cancer	0.000619	0.00581	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.000605	0.00568	CcSEcCtD
Rescinnamine—Myocardial infarction—Vinorelbine—ovarian cancer	0.000602	0.00565	CcSEcCtD
Rescinnamine—Injury—Paclitaxel—ovarian cancer	0.000583	0.00547	CcSEcCtD
Rescinnamine—Redness—Doxorubicin—ovarian cancer	0.000578	0.00543	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Doxorubicin—ovarian cancer	0.000573	0.00538	CcSEcCtD
Rescinnamine—Herpes zoster—Epirubicin—ovarian cancer	0.00056	0.00526	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vinorelbine—ovarian cancer	0.000548	0.00515	CcSEcCtD
Rescinnamine—Back pain—Topotecan—ovarian cancer	0.000542	0.00509	CcSEcCtD
Rescinnamine—Gingivitis—Epirubicin—ovarian cancer	0.000538	0.00505	CcSEcCtD
Rescinnamine—Abscess—Epirubicin—ovarian cancer	0.000533	0.005	CcSEcCtD
Rescinnamine—Stinging—Epirubicin—ovarian cancer	0.000521	0.00489	CcSEcCtD
Rescinnamine—Herpes zoster—Doxorubicin—ovarian cancer	0.000519	0.00487	CcSEcCtD
Rescinnamine—Infection—Chlorambucil—ovarian cancer	0.000511	0.00479	CcSEcCtD
Rescinnamine—Gingivitis—Doxorubicin—ovarian cancer	0.000497	0.00467	CcSEcCtD
Rescinnamine—Abscess—Doxorubicin—ovarian cancer	0.000493	0.00463	CcSEcCtD
Rescinnamine—Cough—Topotecan—ovarian cancer	0.000489	0.00459	CcSEcCtD
Rescinnamine—Stinging—Doxorubicin—ovarian cancer	0.000482	0.00452	CcSEcCtD
Rescinnamine—Erythema—Vinorelbine—ovarian cancer	0.00048	0.0045	CcSEcCtD
Rescinnamine—Cough—Melphalan—ovarian cancer	0.000479	0.0045	CcSEcCtD
Rescinnamine—Myalgia—Topotecan—ovarian cancer	0.000477	0.00448	CcSEcCtD
Rescinnamine—Dermatitis bullous—Docetaxel—ovarian cancer	0.000475	0.00446	CcSEcCtD
Rescinnamine—Discomfort—Topotecan—ovarian cancer	0.000472	0.00443	CcSEcCtD
Rescinnamine—Myalgia—Melphalan—ovarian cancer	0.000467	0.00439	CcSEcCtD
Rescinnamine—Skin discolouration—Epirubicin—ovarian cancer	0.000467	0.00438	CcSEcCtD
Rescinnamine—Back pain—Vinorelbine—ovarian cancer	0.000464	0.00435	CcSEcCtD
Rescinnamine—Influenza—Paclitaxel—ovarian cancer	0.000463	0.00435	CcSEcCtD
Rescinnamine—Cough increased—Epirubicin—ovarian cancer	0.000461	0.00433	CcSEcCtD
Rescinnamine—Lacrimation increased—Epirubicin—ovarian cancer	0.000458	0.0043	CcSEcCtD
Rescinnamine—Infection—Topotecan—ovarian cancer	0.000455	0.00427	CcSEcCtD
Rescinnamine—Oedema—Melphalan—ovarian cancer	0.000448	0.00421	CcSEcCtD
Rescinnamine—Bronchitis—Paclitaxel—ovarian cancer	0.000445	0.00418	CcSEcCtD
Rescinnamine—Infection—Melphalan—ovarian cancer	0.000445	0.00418	CcSEcCtD
Rescinnamine—Pain—Chlorambucil—ovarian cancer	0.00044	0.00413	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—ovarian cancer	0.000432	0.00406	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—ovarian cancer	0.000426	0.004	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—ovarian cancer	0.000424	0.00398	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.000423	0.00397	CcSEcCtD
Rescinnamine—Vaginal inflammation—Epirubicin—ovarian cancer	0.000422	0.00396	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00042	0.00395	CcSEcCtD
Rescinnamine—Cough—Vinorelbine—ovarian cancer	0.000419	0.00393	CcSEcCtD
Rescinnamine—Dermatitis contact—Epirubicin—ovarian cancer	0.000417	0.00391	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000417	0.00391	CcSEcCtD
Rescinnamine—Hypertension—Vinorelbine—ovarian cancer	0.000414	0.00389	CcSEcCtD
Rescinnamine—Paraesthesia—Topotecan—ovarian cancer	0.000411	0.00386	CcSEcCtD
Rescinnamine—Urticaria—Chlorambucil—ovarian cancer	0.000408	0.00383	CcSEcCtD
Rescinnamine—Myalgia—Vinorelbine—ovarian cancer	0.000408	0.00383	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000408	0.00383	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000407	0.00382	CcSEcCtD
Rescinnamine—Abdominal pain—Chlorambucil—ovarian cancer	0.000406	0.00381	CcSEcCtD
Rescinnamine—Myocardial infarction—Paclitaxel—ovarian cancer	0.000405	0.0038	CcSEcCtD
Rescinnamine—Discomfort—Vinorelbine—ovarian cancer	0.000404	0.00379	CcSEcCtD
Rescinnamine—Paraesthesia—Melphalan—ovarian cancer	0.000402	0.00378	CcSEcCtD
Rescinnamine—Conjunctivitis—Paclitaxel—ovarian cancer	0.000401	0.00377	CcSEcCtD
Rescinnamine—Urinary tract infection—Paclitaxel—ovarian cancer	0.000401	0.00377	CcSEcCtD
Rescinnamine—Vaginal infection—Epirubicin—ovarian cancer	0.000398	0.00374	CcSEcCtD
Rescinnamine—Constipation—Topotecan—ovarian cancer	0.000391	0.00367	CcSEcCtD
Rescinnamine—Pain—Topotecan—ovarian cancer	0.000391	0.00367	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00039	0.00366	CcSEcCtD
Rescinnamine—Infection—Vinorelbine—ovarian cancer	0.000389	0.00365	CcSEcCtD
Rescinnamine—Sinusitis—Paclitaxel—ovarian cancer	0.000387	0.00364	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—ovarian cancer	0.000386	0.00362	CcSEcCtD
Rescinnamine—Pain—Melphalan—ovarian cancer	0.000383	0.0036	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—ovarian cancer	0.000382	0.00359	CcSEcCtD
Rescinnamine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000379	0.00355	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000374	0.00351	CcSEcCtD
Rescinnamine—Rhinitis—Paclitaxel—ovarian cancer	0.000372	0.00349	CcSEcCtD
Rescinnamine—Hypertonia—Epirubicin—ovarian cancer	0.00037	0.00347	CcSEcCtD
Rescinnamine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000369	0.00346	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—ovarian cancer	0.000369	0.00346	CcSEcCtD
Rescinnamine—Pharyngitis—Paclitaxel—ovarian cancer	0.000368	0.00345	CcSEcCtD
Rescinnamine—Pruritus—Chlorambucil—ovarian cancer	0.000364	0.00341	CcSEcCtD
Rescinnamine—Urticaria—Topotecan—ovarian cancer	0.000364	0.00341	CcSEcCtD
Rescinnamine—Abdominal pain—Topotecan—ovarian cancer	0.000362	0.0034	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000357	0.00335	CcSEcCtD
Rescinnamine—Urticaria—Melphalan—ovarian cancer	0.000356	0.00334	CcSEcCtD
Rescinnamine—Paraesthesia—Vinorelbine—ovarian cancer	0.000352	0.0033	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000345	0.00324	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—ovarian cancer	0.000343	0.00322	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—ovarian cancer	0.000342	0.00321	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—ovarian cancer	0.00034	0.00319	CcSEcCtD
Rescinnamine—Hypersensitivity—Topotecan—ovarian cancer	0.000337	0.00316	CcSEcCtD
Rescinnamine—Pain—Vinorelbine—ovarian cancer	0.000335	0.00314	CcSEcCtD
Rescinnamine—Constipation—Vinorelbine—ovarian cancer	0.000335	0.00314	CcSEcCtD
Rescinnamine—Hypersensitivity—Melphalan—ovarian cancer	0.00033	0.0031	CcSEcCtD
Rescinnamine—Pruritus—Topotecan—ovarian cancer	0.000324	0.00304	CcSEcCtD
Rescinnamine—Erythema—Paclitaxel—ovarian cancer	0.000323	0.00303	CcSEcCtD
Rescinnamine—Dermatitis bullous—Epirubicin—ovarian cancer	0.00032	0.00301	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00032	0.003	CcSEcCtD
Rescinnamine—Pruritus—Melphalan—ovarian cancer	0.000317	0.00298	CcSEcCtD
Rescinnamine—Dysgeusia—Paclitaxel—ovarian cancer	0.000316	0.00297	CcSEcCtD
Rescinnamine—Rhinitis—Docetaxel—ovarian cancer	0.000315	0.00296	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—ovarian cancer	0.000313	0.00293	CcSEcCtD
Rescinnamine—Back pain—Paclitaxel—ovarian cancer	0.000312	0.00293	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—ovarian cancer	0.000312	0.00293	CcSEcCtD
Rescinnamine—Urticaria—Vinorelbine—ovarian cancer	0.000311	0.00292	CcSEcCtD
Rescinnamine—Abdominal pain—Vinorelbine—ovarian cancer	0.000309	0.0029	CcSEcCtD
Rescinnamine—Nausea—Chlorambucil—ovarian cancer	0.000305	0.00287	CcSEcCtD
Rescinnamine—Dizziness—Topotecan—ovarian cancer	0.000303	0.00284	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000297	0.00278	CcSEcCtD
Rescinnamine—Rash—Topotecan—ovarian cancer	0.000289	0.00271	CcSEcCtD
Rescinnamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000288	0.00271	CcSEcCtD
Rescinnamine—Dermatitis—Topotecan—ovarian cancer	0.000288	0.00271	CcSEcCtD
Rescinnamine—Headache—Topotecan—ovarian cancer	0.000287	0.00269	CcSEcCtD
Rescinnamine—Rash—Melphalan—ovarian cancer	0.000283	0.00265	CcSEcCtD
Rescinnamine—Dermatitis—Melphalan—ovarian cancer	0.000282	0.00265	CcSEcCtD
Rescinnamine—Cough—Paclitaxel—ovarian cancer	0.000282	0.00264	CcSEcCtD
Rescinnamine—Hypertension—Paclitaxel—ovarian cancer	0.000279	0.00261	CcSEcCtD
Rescinnamine—Pruritus—Vinorelbine—ovarian cancer	0.000277	0.0026	CcSEcCtD
Rescinnamine—Myalgia—Paclitaxel—ovarian cancer	0.000275	0.00258	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—ovarian cancer	0.000273	0.00257	CcSEcCtD
Rescinnamine—Nausea—Topotecan—ovarian cancer	0.000272	0.00255	CcSEcCtD
Rescinnamine—Discomfort—Paclitaxel—ovarian cancer	0.000271	0.00255	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—ovarian cancer	0.000271	0.00254	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—ovarian cancer	0.000268	0.00251	CcSEcCtD
Rescinnamine—Nausea—Melphalan—ovarian cancer	0.000266	0.0025	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—ovarian cancer	0.000265	0.00248	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—ovarian cancer	0.000265	0.00248	CcSEcCtD
Rescinnamine—Oedema—Paclitaxel—ovarian cancer	0.000263	0.00247	CcSEcCtD
Rescinnamine—Infection—Paclitaxel—ovarian cancer	0.000262	0.00246	CcSEcCtD
Rescinnamine—Dizziness—Vinorelbine—ovarian cancer	0.000259	0.00243	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—ovarian cancer	0.000258	0.00242	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—ovarian cancer	0.000255	0.00239	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—ovarian cancer	0.000251	0.00235	CcSEcCtD
Rescinnamine—Rash—Vinorelbine—ovarian cancer	0.000247	0.00232	CcSEcCtD
Rescinnamine—Dermatitis—Vinorelbine—ovarian cancer	0.000247	0.00231	CcSEcCtD
Rescinnamine—Headache—Vinorelbine—ovarian cancer	0.000245	0.0023	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—ovarian cancer	0.000245	0.0023	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000242	0.00227	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00024	0.00225	CcSEcCtD
Rescinnamine—Cough—Docetaxel—ovarian cancer	0.000239	0.00224	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—ovarian cancer	0.000239	0.00224	CcSEcCtD
Rescinnamine—Insomnia—Paclitaxel—ovarian cancer	0.000238	0.00224	CcSEcCtD
Rescinnamine—Paraesthesia—Paclitaxel—ovarian cancer	0.000236	0.00222	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—ovarian cancer	0.000236	0.00222	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—ovarian cancer	0.000236	0.00221	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—ovarian cancer	0.000233	0.00218	CcSEcCtD
Rescinnamine—Nausea—Vinorelbine—ovarian cancer	0.000233	0.00218	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—ovarian cancer	0.000229	0.00215	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—ovarian cancer	0.000229	0.00215	CcSEcCtD
Rescinnamine—Pain—Paclitaxel—ovarian cancer	0.000225	0.00211	CcSEcCtD
Rescinnamine—Constipation—Paclitaxel—ovarian cancer	0.000225	0.00211	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000224	0.0021	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—ovarian cancer	0.000223	0.00209	CcSEcCtD
Rescinnamine—Infection—Docetaxel—ovarian cancer	0.000222	0.00208	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—ovarian cancer	0.000221	0.00208	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000215	0.00202	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—ovarian cancer	0.000212	0.00199	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000212	0.00199	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000212	0.00199	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000211	0.00198	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—ovarian cancer	0.00021	0.00197	CcSEcCtD
Rescinnamine—Urticaria—Paclitaxel—ovarian cancer	0.000209	0.00196	CcSEcCtD
Rescinnamine—Abdominal pain—Paclitaxel—ovarian cancer	0.000208	0.00195	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—ovarian cancer	0.000205	0.00192	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000203	0.00191	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—ovarian cancer	0.000202	0.00189	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—ovarian cancer	0.0002	0.00188	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—ovarian cancer	0.000197	0.00184	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000195	0.00183	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—ovarian cancer	0.000195	0.00183	CcSEcCtD
Rescinnamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000194	0.00182	CcSEcCtD
Rescinnamine—Pain—Docetaxel—ovarian cancer	0.000191	0.00179	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—ovarian cancer	0.000191	0.00179	CcSEcCtD
Rescinnamine—Pruritus—Paclitaxel—ovarian cancer	0.000186	0.00175	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—ovarian cancer	0.000184	0.00173	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000183	0.00171	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—ovarian cancer	0.000181	0.0017	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—ovarian cancer	0.000178	0.00167	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—ovarian cancer	0.000176	0.00166	CcSEcCtD
Rescinnamine—Dizziness—Paclitaxel—ovarian cancer	0.000174	0.00163	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—ovarian cancer	0.000171	0.0016	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—ovarian cancer	0.000167	0.00157	CcSEcCtD
Rescinnamine—Rash—Paclitaxel—ovarian cancer	0.000166	0.00156	CcSEcCtD
Rescinnamine—Dermatitis—Paclitaxel—ovarian cancer	0.000166	0.00156	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—ovarian cancer	0.000165	0.00155	CcSEcCtD
Rescinnamine—Headache—Paclitaxel—ovarian cancer	0.000165	0.00155	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—ovarian cancer	0.000164	0.00154	CcSEcCtD
Rescinnamine—Cough—Epirubicin—ovarian cancer	0.000161	0.00151	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—ovarian cancer	0.000159	0.00149	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—ovarian cancer	0.000158	0.00148	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—ovarian cancer	0.000157	0.00147	CcSEcCtD
Rescinnamine—Nausea—Paclitaxel—ovarian cancer	0.000156	0.00147	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—ovarian cancer	0.000155	0.00146	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—ovarian cancer	0.000151	0.00141	CcSEcCtD
Rescinnamine—Infection—Epirubicin—ovarian cancer	0.00015	0.0014	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—ovarian cancer	0.000149	0.0014	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—ovarian cancer	0.000148	0.00139	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—ovarian cancer	0.000147	0.00138	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—ovarian cancer	0.000145	0.00136	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—ovarian cancer	0.000144	0.00135	CcSEcCtD
Rescinnamine—Rash—Docetaxel—ovarian cancer	0.000141	0.00132	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—ovarian cancer	0.000141	0.00132	CcSEcCtD
Rescinnamine—Headache—Docetaxel—ovarian cancer	0.00014	0.00131	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—ovarian cancer	0.000139	0.00131	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—ovarian cancer	0.000138	0.0013	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000137	0.00129	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—ovarian cancer	0.000136	0.00128	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—ovarian cancer	0.000135	0.00127	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—ovarian cancer	0.000133	0.00124	CcSEcCtD
Rescinnamine—Pain—Epirubicin—ovarian cancer	0.000129	0.00121	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—ovarian cancer	0.000129	0.00121	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000127	0.00119	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—ovarian cancer	0.000126	0.00118	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—ovarian cancer	0.000125	0.00117	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000123	0.00116	CcSEcCtD
Rescinnamine—Urticaria—Epirubicin—ovarian cancer	0.00012	0.00112	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—ovarian cancer	0.000119	0.00112	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—ovarian cancer	0.000119	0.00112	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—ovarian cancer	0.000119	0.00112	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000114	0.00107	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—ovarian cancer	0.000111	0.00104	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—ovarian cancer	0.000111	0.00104	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—ovarian cancer	0.00011	0.00103	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—ovarian cancer	0.000107	0.001	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000103	0.000963	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—ovarian cancer	9.96e-05	0.000934	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—ovarian cancer	9.86e-05	0.000925	CcSEcCtD
Rescinnamine—Rash—Epirubicin—ovarian cancer	9.49e-05	0.000891	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—ovarian cancer	9.48e-05	0.00089	CcSEcCtD
Rescinnamine—Headache—Epirubicin—ovarian cancer	9.43e-05	0.000885	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—ovarian cancer	9.21e-05	0.000864	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—ovarian cancer	8.94e-05	0.000839	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—ovarian cancer	8.78e-05	0.000824	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—ovarian cancer	8.77e-05	0.000823	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—ovarian cancer	8.73e-05	0.000819	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—ovarian cancer	8.27e-05	0.000776	CcSEcCtD
